Literature DB >> 7996384

pH-dependent and carrier-mediated transport of salicylic acid across Caco-2 cells.

H Takanaga1, I Tamai, A Tsuji.   

Abstract

The transport of monocarboxylic acid drugs such as salicylic acid was examined in the human colon adenocarcinoma cell line, Caco-2 cells that possess intestinal epithelia-like properties. [14C]Salicylic acid transport was pH-dependent and appeared to follow the pH-partition hypothesis. However, 10 mM unlabelled salicylic acid significantly reduced the permeability coefficient of [14C]salicylic acid. Kinetic analysis of the concentration dependence of the permeation rate of salicylic acid across Caco-2 cells showed both saturable (Kt = 5.28 +/- 0.72 mM Jmax = 36.6 +/- 3.54 nmol min-1 (mg protein)-1) and nonsaturable (kd = 0.37 +/- 0.08 microL min-1 (mg protein)-1) processes. The permeation rate of [14C]salicylic acid was competitively inhibited by both acetic acid and benzoic acid, which were demonstrated in our previous studies to be transported in the carrier-mediated-transport mechanism which is responsible for monocarboxylic acids. Furthermore, certain monocarboxylic acids significantly inhibited [14C]salicylic acid transport, whereas salicylamide and dicarboxylic acids such as succinic acid did not. From these results, it was concluded that the transcellular transport of [14C]salicylic acid across Caco-2 cells is by the pH-dependent and carrier-mediated transport mechanism specific for monocarboxylic acids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996384     DOI: 10.1111/j.2042-7158.1994.tb03858.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  15 in total

1.  Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines.

Authors:  Pascale Anderle; Vera Rakhmanova; Katie Woodford; Noa Zerangue; Wolfgang Sadée
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

Review 2.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 3.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

4.  Application of fractal kinetics for carrier-mediated transport of drugs across intestinal epithelial membrane.

Authors:  T Ogihara; I Tamai; A Tsuji
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

5.  Possible role of anion exchanger AE2 as the intestinal monocarboxylic acid/anion antiporter.

Authors:  H Yabuuchi; I Tamai; Y Sai; A Tsuji
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

6.  Salicylic acid, an ambimobile molecule exhibiting a high ability to accumulate in the phloem.

Authors:  Françoise Rocher; Jean-François Chollet; Cyril Jousse; Jean-Louis Bonnemain
Journal:  Plant Physiol       Date:  2006-06-15       Impact factor: 8.340

7.  Stereoselective and carrier-mediated transport of monocarboxylic acids across Caco-2 cells.

Authors:  T Ogihara; I Tamai; H Takanaga; Y Sai; A Tsuji
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

8.  Salicylic acid transport in Ricinus communis involves a pH-dependent carrier system in addition to diffusion.

Authors:  Françoise Rocher; Jean-François Chollet; Sandrine Legros; Cyril Jousse; Rémi Lemoine; Mireille Faucher; Daniel R Bush; Jean-Louis Bonnemain
Journal:  Plant Physiol       Date:  2009-06-03       Impact factor: 8.340

9.  In Vivo and In Vitro Evidence for Brain Uptake of 4-Phenylbutyrate by the Monocarboxylate Transporter 1 (MCT1).

Authors:  Na-Young Lee; Young-Sook Kang
Journal:  Pharm Res       Date:  2016-03-29       Impact factor: 4.200

10.  Proton-cotransport of pravastatin across intestinal brush-border membrane.

Authors:  I Tamai; H Takanaga; H Maeda; T Ogihara; M Yoneda; A Tsuji
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.